Axa Venture Partners, a global venture capital firm investing in high-growth, technology-enabled companies, has launched a new strategy to invest in late-stage tech companies with a targeted €1.5bn fund of which €750m invested by AXA.
The first closing is expected in Q1 2024 with a final close expected in 2025. AXA intends to invest €750m, as anchor investor, in a new Late Growth strategy, which will invest in global tech leaders in Europe and North America. It will support them until the IPO and will potentially, as a long-term investor, remain invested post-IPO.
The strategy will target AVP’s existing focus sectors of Software, Fintech/Insurtech, Digital Health and Consumer technologies in Europe and in North America. It will invest in companies that have fully proven product market fit and sales execution in one or several markets, that intend to continue their growth through global expansion and have the potential to IPO in the next three to four years.
AVP Late Growth strategy will lead rounds with initial investment size of up to €150m and be an active investor with Board representation. The future fund will build a portfolio of 12/15 promising late-stage tech companies.
The future fund naturally extends the current range of AVP funds (Venture, Growth and Funds of Funds) and broadens the AVP capacity to invest in all stages of tech companies. The firm will reinforce its team in Europe and North America with new talent to support this strategy.
Part of AXA IM- Alts, the alternative investment business unit of AXA IM, AXA Venture Partners has €1.3bn of assets under management through three pillars of investment expertise: early stage, growth stage, and fund of funds. Since its launch in 2016, the firm deployed capital across 60 technology companies in Venture and Growth stages in the US and in Europe.
It has offices in New York, London and Paris.
FinSMEs
26/05/2023